NLRP3 and epilepsy syndrome: Curcumin has been reported to inhibit IL-1β release and prevent inflammation via the inhibition of NLRP3 [184] and suppressed KA-induced epileptic syndrome via inhibiting NLRP3 inflammasome activation in Sprague Dawley rats [68].